{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:05:53Z","timestamp":1791378353448,"version":"4.3.2"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12328-026-02395-0","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:07:26Z","timestamp":1783919246000},"page":"1075-1081","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A young pregnant woman with oesophageal cancer who responded to carboplatin plus nab-paclitaxel therapy"],"prefix":"10.1007","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6070-6927","authenticated-orcid":false,"given":"Yoshinori","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehiro","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naobumi","family":"Tochigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuro","family":"Terahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"6","key":"2395_CR1","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1007\/s12328-020-01237-x","volume":"13","author":"DJ Uhlenhopp","year":"2020","unstructured":"Uhlenhopp DJ, Then EO, Sunkara T, et al. Epidemiology of esophageal cancer: update in global trends, etiology and risk factors. Clin J Gastroenterol. 2020;13(6):1010\u201321.","journal-title":"Clin J Gastroenterol"},{"key":"2395_CR2","unstructured":"NCCN guidelines for patients esophageal cancer. Available from: https:\/\/www.nccn.org\/guidelines\/patients. Accessed 30 June 2025."},{"issue":"3","key":"2395_CR3","first-page":"279","volume":"40","author":"H Ide","year":"2005","unstructured":"Ide H. Macroscopic findings of non-squamous cell carcinoma of the esophagus. Stomach Intestine. 2005;40(3):279\u201387. (in Japanese).","journal-title":"Stomach Intestine"},{"issue":"10302","key":"2395_CR4","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0140-6736(21)01234-4","volume":"398","author":"JM Sun","year":"2021","unstructured":"Sun JM, Shen L, Shah MA, et al. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study. Lancet. 2021;398(10302):759\u201371.","journal-title":"Lancet"},{"issue":"5","key":"2395_CR5","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1056\/NEJMoa2111380","volume":"386","author":"Y Doki","year":"2022","unstructured":"Doki Y, Ajani JA, Kato K, et al. Nivolumab combination therapy in advanced esophageal squamous-cell carcinoma. N Engl J Med. 2022;386(5):449\u201362.","journal-title":"N Engl J Med"},{"issue":"4","key":"2395_CR6","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1158\/1078-0432.CCR-05-1634","volume":"12","author":"N Desai","year":"2006","unstructured":"Desai N, Trieu V, Yao Z, et al. Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res. 2006;12(4):1317\u201324.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2395_CR7","doi-asserted-by":"publisher","first-page":"268","DOI":"10.7150\/jca.12986","volume":"7","author":"HH Loong","year":"2016","unstructured":"Loong HH, Chan ACY, Ashley CY, Wong ACY. Evolving evidence of the efficacy and safety of nab-paclitaxel in the treatment of cancers with squamous histologies. J Cancer. 2016;7(3):268\u201375.","journal-title":"J Cancer"},{"key":"2395_CR8","unstructured":"National cancer center. Available from: https:\/\/ganjoho.jp\/reg_stat\/statistics\/data\/dl\/index.html#a14. Accessed 30 June 2025."},{"key":"2395_CR9","unstructured":"Guidelines for diagnosis and treatment of carcinoma of the esophagus. 2022, 5th Edition. Edited by The Japan Esophageal Society (in Japanese)."},{"issue":"6","key":"2395_CR10","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s00280-010-1422-x","volume":"67","author":"K Kato","year":"2011","unstructured":"Kato K, Tahara M, Hironaka S, et al. A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy. Cancer Chemother Pharmacol. 2011;67(6):1265\u201372.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2395_CR11","unstructured":"Practical guideline for carcinoma of unknown primary. 2nd Edition. Edited by The Japanese Society of Medical Oncology (in Japanese)."},{"key":"2395_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.21037\/med-22-48","volume":"7","author":"F Nehme","year":"2023","unstructured":"Nehme F, Ge PS, Coronel E. Management of aero-digestive fistulas: the gastroenterologist\u2019s perspective, a narrative review. Mediastinum. 2023;7:34. https:\/\/doi.org\/10.21037\/med-22-48.","journal-title":"Mediastinum"},{"key":"2395_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s40880-016-0171-6","volume":"36","author":"L Ma","year":"2017","unstructured":"Ma L, Luo GY, Ren YF, et al. Concurrent chemoradiotherapy combined with enteral nutrition support: a radical treatment strategy for esophageal squamous cell carcinoma patients with malignant fistulae. Chin J Cancer. 2017;36:8.","journal-title":"Chin J Cancer"},{"key":"2395_CR14","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1406::AID-CNCR4>3.0.CO;2-3","volume":"86","author":"M Muto","year":"1999","unstructured":"Muto M, Ohtsu A, Miyamoto S, et al. Concurrent chemoradiotherapy for esophageal carcinoma patients with malignant fistulae. Cancer. 1999;86:1406\u201313.","journal-title":"Cancer"},{"issue":"17","key":"2395_CR15","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1200\/JCO.2011.39.5848","volume":"30","author":"MA Socinski","year":"2012","unstructured":"Socinski MA, Bondarenko I, Nina A, Karaseva NA, et al. Weekly nab-paclitaxel in combination with carboplatin versus solvent-based paclitaxel plus carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: final results of a phase III trial. J Clin Oncol. 2012;30(17):2055\u201362.","journal-title":"J Clin Oncol"},{"issue":"6","key":"2395_CR16","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.cllc.2014.07.003","volume":"15","author":"GR Simon","year":"2014","unstructured":"Simon GR. nab-Paclitaxel for the treatment of advanced squamous non-small-cell lung cancer: a comprehensive update. Clin Lung Cancer. 2014;15(6):391\u20137.","journal-title":"Clin Lung Cancer"},{"key":"2395_CR17","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.2147\/DDDT.S155750","volume":"12","author":"C Gridelli","year":"2018","unstructured":"Gridelli C, Chen T, Ko A, et al. nab-Paclitaxel\/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III tria. Drug Des Devel Ther. 2018;12:1445\u201351.","journal-title":"Drug Des Devel Ther"},{"key":"2395_CR18","doi-asserted-by":"publisher","unstructured":"Ley J, Wildes TM, Daly K et al. Clinical benefit of nanoparticle albumin-bound-paclitaxel in recurrent\/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel. Med oncol.2017;34(2):28. https:\/\/doi.org\/10.1007\/s12032-017-0884-7","DOI":"10.1007\/s12032-017-0884-7"},{"key":"2395_CR19","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2147\/OTT.S44406","volume":"6","author":"Y Shi","year":"2013","unstructured":"Shi Y, Qin R, Wang Z-K, et al. Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma. Onco Targets Ther. 2013;6:585\u201391.","journal-title":"Onco Targets Ther"},{"issue":"31","key":"2395_CR20","doi-asserted-by":"publisher","first-page":"50624","DOI":"10.18632\/oncotarget.9562","volume":"7","author":"Y Fan","year":"2016","unstructured":"Fan Y, Jiang Y, Zhou X, et al. Phase II study of neoadjuvant therapy with nab-paclitaxel and cisplatin followed by surgery in patients with locally advanced esophageal squamous cell carcinoma. Oncotarget. 2016;7(31):50624\u201334.","journal-title":"Oncotarget"},{"issue":"12","key":"2395_CR21","doi-asserted-by":"publisher","first-page":"4993","DOI":"10.7314\/APJCP.2015.16.12.4993","volume":"16","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Zhang Y, Shi L, et al. Clinical research on albumin-bound paclitaxel-based chemotherapy for advanced esophageal cancer. Asian Pac J Cancer Prev. 2016;16(12):4993\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"2395_CR22","doi-asserted-by":"publisher","first-page":"5663","DOI":"10.2147\/OTT.S108580","volume":"9","author":"H-Y Wang","year":"2016","unstructured":"Wang H-Y, Yao Z-Y, Tang H, et al. Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma. Onco Targets Ther. 2016;9:5663\u20139.","journal-title":"Onco Targets Ther"},{"issue":"11","key":"2395_CR23","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1158\/1078-0432.CCR-04-2291","volume":"11","author":"A Sparreboom","year":"2005","unstructured":"Sparreboom A, Scripture CD, Trieu V, et al. Comparative preclinical and clinical pharmacokinetics of a cremophor-free, nanoparticle albumin-bound paclitaxel (ABI-007) and paclitaxel formulated in Cremophor (Taxol). Clin Cancer Res. 2005;11(11):4136\u201343.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2395_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13014-021-01821-6","volume":"16","author":"X-L Zhou","year":"2021","unstructured":"Zhou X-L, Yu C-H, Wang W-W, et al. Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma. Radiat Oncol. 2021;16(1):94. https:\/\/doi.org\/10.1186\/s13014-021-01821-6.","journal-title":"Radiat Oncol"},{"issue":"3","key":"2395_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000495700","volume":"42","author":"S Sun","year":"2019","unstructured":"Sun S, Yu H, Wang H, et al. Phase II study of S-1 plus cisplatin as first-line therapy in patients with metastatic esophageal carcinoma. Oncol Res Treat. 2019;42(3):115\u201322.","journal-title":"Oncol Res Treat"},{"key":"2395_CR26","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2176\/nmc.23.619","volume":"23","author":"K Harada","year":"1983","unstructured":"Harada K, Okamoto H, Kiya K, et al. Pharmacokinetics study of UFT in malignant tumor patient. Neural Med Chir (Tokyo). 1983;23:619\u201324. (in Japanese).","journal-title":"Neural Med Chir (Tokyo)"},{"issue":"4","key":"2395_CR27","first-page":"729","volume":"3","author":"T Kohno","year":"1976","unstructured":"Kohno T, Shitara N, Takakura K, et al. Treatment of metastatic brain tumors with FT-207. Japanese J Cancer Chemother. 1976;3(4):729\u201334. (in Japanese).","journal-title":"Japanese J Cancer Chemother"},{"issue":"2","key":"2395_CR28","doi-asserted-by":"publisher","first-page":"593","DOI":"10.3390\/ijms22020593","volume":"22","author":"A Rybarczyk-Kasiuchnicz","year":"2021","unstructured":"Rybarczyk-Kasiuchnicz A, Ramlau R, Stencel K. Treatment of brain metastases of non-small cell lung carcinoma. Int J Mol Sci. 2021;22(2):593. https:\/\/doi.org\/10.3390\/ijms22020593.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"2395_CR29","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","volume":"21","author":"A Marabelle","year":"2020","unstructured":"Marabelle A, Fakih M, Lopez J, et al. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol. 2020;21(10):1353\u201365. https:\/\/doi.org\/10.1016\/S1470-2045(20)30445-9.","journal-title":"Lancet Oncol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-026-02395-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-026-02395-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:43:01Z","timestamp":1791376981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-026-02395-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["2395"],"URL":"https:\/\/doi.org\/10.1007\/s12328-026-02395-0","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study does not contain identifying information of the patients. Permission for this publication was obtained from the patient.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}